Health Care

Krsnaa Diagnostics Ltd (KRSNAA) Q3 FY23 Earnings Concall Transcript

● Feb 15, 2023

Krsnaa Diagnostics Ltd (NSE:KRSNAA) Q3 FY23 Earnings Concall dated Feb. 14, 2023. Corporate Participants: Pallavi Bhatevara — Managing Director Pawan Daga — Chief Financial...

Marksans Pharma Limited (MARKSANS) Q3 FY23 Earnings Concall Transcript

● Feb 15, 2023

Marksans Pharma Limited (NSE:MARKSANS) Q3 FY23 Earnings Concall dated Feb. 14, 2023. Corporate Participants: Mark Saldanha — Managing Director and Chief Executive...

Vijaya Diagnostic Centre Limited (VIJAYA) Q3 FY23 Earnings Concall Transcript

● Feb 15, 2023

Biocon ltd.(NSE: BIOCON) Ltd. : Q3 FY23 Results Out; Total Income rise 35% YoY

● Feb 14, 2023

Biocon Limited (NSE:BIOCON) is an Indian multinational biopharmaceutical company based in Bangalore, India. The company was founded in 1978 by...

Brooks Laboratories Ltd.(NSE: BROOKS) Ltd. : Q3 FY23 Results Out; Total Income fell 20% YoY

● Feb 14, 2023

Brooks Laboratories Limited (NSE: BROOKS) is a pharmaceutical contract research and manufacturing services company based in India. It offers a...

Themis Medicare Ltd (THEMISMED) Q3 FY23 Earnings Concall Transcript

● Feb 14, 2023

Themis Medicare Ltd (NSE:THEMISMED) Q3 FY23 Earnings Concall dated Feb. 10, 2023. Corporate Participants: Sachin D. Patel — Managing Director and Chief...

Rainbow Children’s Medicare Ltd (RAINBOW) Q3 FY23 Earnings Concall Transcript

● Feb 14, 2023

Rainbow Children’s Medicare Ltd (NSE:RAINBOW) Q3 FY23 Earnings Concall dated Feb. 10, 2023. Corporate Participants: Ramesh Kancharla — Chairman and Managing Director...

Panacea Biotec Q3FY23; 26% Fall in Revenue

● Feb 14, 2023

Panacea Biotec Limited’s revenue in Q3FY23 fell 26% to ₹ 11,520 lakhs. Consolidated Profit After Tax came at ₹ 1,937...

Fortis Healthcare Ltd (FORTIS) Q3 FY23 Earnings Concall Transcript

● Feb 14, 2023

Fortis Healthcare Ltd (NSE:FORTIS) Q3 FY23 Earnings Concall dated Feb. 13, 2023. Corporate Participants: Anurag Kalra — Senior Vice President, Investor Relations...

Glenmark Pharmaceuticals Limited (GLENMARK) Q3 FY23 Earnings Concall Transcript

● Feb 14, 2023

Glenmark Pharmaceuticals Limited (NSE:GLENMARK) Q3 FY23 Earnings Concall dated Feb. 13, 2023. Corporate Participants: Utkarsh Gandhi — General Manager, Investor Relations Glenn...